Lataa...
Adverse events in a newborn on valproate therapy due to loss-of-function mutations in CYP2C9
An increased risk of valproate-induced toxicity has been reported in children, particularly in those younger than 2 years of age. Significant variations in valproate pharmacokinetics and shifts in the metabolic pathways towards CYP2C9-dependent metabolism seem to play some role in the age-related di...
Tallennettuna:
| Julkaisussa: | Epilepsy Behav Case Rep |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4588450/ https://ncbi.nlm.nih.gov/pubmed/26543813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebcr.2015.08.006 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|